Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
23 May 2019
Day 1: Thursday, 23 May 2019
BLOCK: FORMULATION, DEVELOPMENT & DESIGN.
CASE STUDY: Probing the Aerodynamic Particle Size Distribution of Dry Powder Inhaler Combination Products Foster® NEXThaler® and Seretide® Diskus® using Single Particle Aerosol Mass Spectrometry (SPAMS).